The FDA is announcing the approval of Trumenba, the first vaccine approved in the United States to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroup B in individuals 10 through 25 years of age.
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3bdjiwl
No comments:
Post a Comment